Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares (NQ:KNSA)

44.72 +0.80 (+1.81%)
Streaming Delayed Price Updated: 3:57 PM EST, Feb 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 299,077
Open 43.65
Bid (Size) 44.70 (400)
Ask (Size) 44.73 (2,200)
Prev. Close 43.92
Today's Range 43.65 - 45.02
52wk Range 18.12 - 45.00
Shares Outstanding 71,726,685
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Combines High Growth Momentum with Strong Technical Setup ↗
Via Chartmill
News headline image
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Fits the High-Growth Momentum and Trend Template Strategy ↗
KNSA stock meets Minervini's Trend Template with strong technicals and high-growth fundamentals, including surging EPS and revenue. 
Via Chartmill

Performance

YTD
+6.5%
+6.5%
1 Month
+6.5%
+6.5%
3 Month
+19.3%
+19.3%
6 Month
+35.7%
+35.7%
1 Year
+136.8%
+136.8%

More News

Read More
News headline image
Kiniksa (KNSA) Q3 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Combines Technical Strength and Fundamental Growth Momentum ↗
Via Chartmill
News headline image
Earnings Scheduled For October 28, 2025 ↗
Via Benzinga
News headline image
What to Expect from Kiniksa Pharmaceuticals's Earnings ↗
Via Benzinga
News headline image
Earnings Scheduled For July 29, 2025 ↗
Via Benzinga
News headline image
Earnings Preview: Kiniksa Pharmaceuticals ↗
Via Benzinga
News headline image
5 Analysts Have This To Say About Kiniksa Pharmaceuticals ↗
Via Benzinga
News headline image
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Identified by High Growth Momentum and Minervini Trend Screen ↗
Via Chartmill
News headline image
What Analysts Are Saying About Kiniksa Pharmaceuticals Stock ↗
Via Benzinga
News headline image
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Shows High-Growth Momentum and Strong Technical Setup ↗
Via Chartmill
News headline image
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Emerges as an Affordable Growth Opportunity ↗
Via Chartmill
News headline image
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Emerges as a Top Affordable Growth Candidate ↗
Via Chartmill
News headline image
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Exhibits High Growth Momentum and Technical Breakout Potential ↗
Via Chartmill
News headline image
KINIKSA PHARMACEUTICALS INTE (NASDAQ:KNSA): A Strong Growth Stock with a Positive Technical Breakout ↗
Via Chartmill
News headline image
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) – An Affordable Growth Stock with Strong Fundamentals and Fair Valuation ↗
Via Chartmill
News headline image
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Aligns with Minervini’s Trend Model as a Strong Momentum Pick ↗
Via Chartmill
News headline image
Why CommScope Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
Gilead Sciences Reports Earnings Thursday. Can The Highly Ranked Drugmaker Beat Its 237% Profit Surge Last Quarter? ↗
Via Investor's Business Daily
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
Via Benzinga
News headline image
Kiniksa Pharmaceuticals: A 7.9 Score and Room for Growth ↗
Via The Motley Fool
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
Via Benzinga
News headline image
Pony AI, Hims & Hers And Frontdoor Are Among Top 11 Mid-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio? ↗
Via Benzinga
Topics Artificial Intelligence
News headline image
Kiniksa Pharmaceuticals Announces GRAMMY® Award-Winning Country Star, Carly Pearce, Joins the Life DisRPted™ Campaign, Adding to Voices Advocating for Awareness of Recurrent Pericarditis
From Kiniksa Pharmaceuticals, Ltd.
Via GlobeNewswire

Frequently Asked Questions

Is Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares publicly traded?
Yes, Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares is publicly traded.
What exchange does Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares trade on?
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares?
The ticker symbol for Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares is KNSA on the Nasdaq Stock Market
What is the current price of Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares?
The current price of Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares is 44.72
When was Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares last traded?
The last trade of Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares was at 02/02/26 03:57 PM ET
What is the market capitalization of Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares?
The market capitalization of Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares is 3.21B
How many shares of Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares are outstanding?
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares has 3B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.